Search

Objective: Noninvasive ventilation (NIV) is often applied with ICU ventilators. However, leaks at the patient-ventilator interface interfere with several key ventilator functions. Many ICU ventilators feature an NIV-specific mode dedicated to preventing these problems. The present bench model study aimed to evaluate the performance of these modes. Design and setting: Bench model study in an intensive care research laboratory of auniversity hospital. Methods: Eight ICU ventilators, widely available in Europe and featuring an NIV mode, were connected by an NIV mask to alung model featuring aplastic head to mimic NIV conditions, driven by an ICU ventilator imitating patient effort. Tests were conducted in the absence and presence of leaks, the latter condition with and without activation of the NIV mode. Trigger delay, trigger-associated inspiratory workload, and pressurization were tested in conditions of normal respiratory mechanics, and cycling was also assessed in obstructive and restrictive conditions. Results: On most ventilators leaks led to an increase in trigger delay and workload, adecrease in pressurization, and delayed cycling. On most ventilators the NIV mode partly or totally corrected these problems, but with large variations between machines. Furthermore, on some ventilators the NIV mode worsened the leak-induced dysfunction. Conclusions: The results of this bench-model NIV study confirm that leaks interfere with several key functions of ICU ventilators. Overall, NIV modes can correct part or all of this interference, but with wide variations between machines in terms of efficiency. Clinicians should be aware of these differences when applying NIV with an ICU ventilator

Objective: To evaluate the impact of helium-oxygen (He/O2) on inspiratory effort and work of breathing (WOB) in intubated COPD patients ventilated with pressure support. Design and setting: Prospective crossover interventional study in the medical ICU of a university hospital. Patients and participants: Ten patients. Interventions: Sequential inhalation (30min each) of three gas mixtures: (a) air/O2, (b) He/O2 (c) air/O2, at constant FIO2 and level of pressure support. Measurements and results: Inspiratory effort and WOB were determined by esophageal and gastric pressure. Throughout the study pressure support and FIO2 were 14±3cmH2O and 0.33±0.07 respectively. Compared to Air/O2, He/O2 reduced the number of ineffective breaths (4±5 vs. 9±5 breaths/min), intrinsic PEEP (3.1±2 vs. 4.8±2cmH2O), the magnitude of negative esophageal pressure swings (6.7±2 vs. 9.1±4.9cmH2O), pressure-time product (42±37 vs. 67±65cmH2Os−1min−1), and total WOB (11±3 vs. 18±10J/min). Elastic (6±1 vs. 10±6J/min) and resistive (5±1 vs. 9±4J/min) components of the WOB were decreased by He/O2. Conclusions: In intubated COPD patients ventilated with pressure support He/O2 reduces intrinsic PEEP, the number of ineffective breaths, and the magnitude of inspiratory effort and WOB. He/O2 could prove useful in patients with high levels of PEEPi and WOB ventilated in pressure support, for example, during weaning

To compare the effects of He/O(2) and external PEEP (PEEPe) on intrinsic PEEP (PEEPi), respiratory mechanics, gas exchange, and ventilation/perfusion (V(A)/Q) in mechanically ventilated COPD patients.Prospective, interventional study in the intensive care unit of a university hospital.Ten intubated, sedated, paralyzed, mechanically ventilated COPD patients studied in the following conditions: (a) baseline settings made by clinician in charge, air/O(2), ZEEP; (b) He/O(2), ZEEP; (c) air/O(2), ZEEP; (d) air/O(2), PEEPe 80% of PEEPi. Measurements at each condition included V(A)/Q by the multiple inert gas elimination technique (MIGET).PEEPi and trapped gas volume were comparably reduced by He/O(2) (4.2+/-4 vs. 7.7+/-4 cmH(2)O and 98+/-82 vs. 217+/-124 ml, respectively) and PEEPe (4.4+/-1.3 vs. 7.8+/-3.6 cmH(2)O and 120+/-107 vs. 216+/-115 ml, respectively). He/O(2) reduced inspiratory and expiratory respiratory system resistance (15.5+/-4.4 vs. 20.7+/-6.9 and 19+/-9 vs. 28.8+/-15 cmH(2)O l(-1)s(-1), respectively) and plateau pressure (13+/-4 vs. 17+/-6 cmH(2)O). PEEPe increased airway pressures, including total PEEP, and elastance. PaO(2)/FIO(2) was slightly reduced by He/O(2) (225+/-83 vs. 245+/-82) without significant V(A)/Q change.He/O(2) and PEEPe comparably reduced PEEPi and trapped gas volume. However, He/O(2) decreased airway resistance and intrathoracic pressures, at a small cost in arterial oxygenation. He/O(2) could offer an attractive option in COPD patients with PEEPi/dynamic hyperinflation.

Purpose: To determine if, compared to pressure support (PS), neurally adjusted ventilatory assist (NAVA) reduces patient-ventilator asynchrony in intensive care patients undergoing noninvasive ventilation with an oronasal face mask. Methods: In this prospective interventional study we compared patient-ventilator synchrony between PS (with ventilator settings determined by the clinician) and NAVA (with the level set so as to obtain the same maximal airway pressure as in PS). Two 20-min recordings of airway pressure, flow and electrical activity of the diaphragm during PS and NAVA were acquired in a randomized order. Trigger delay (T d), the patient's neural inspiratory time (T in), ventilator pressurization duration (T iv), inspiratory time in excess (T iex), number of asynchrony events per minute and asynchrony index (AI) were determined. Results: The study included 13 patients, six with COPD, and two with mixed pulmonary disease. T d was reduced with NAVA: median 35ms (IQR 31-53ms) versus 181ms (122-208ms); p=0.0002. NAVA reduced both premature and delayed cyclings in the majority of patients, but not the median T iex value. The total number of asynchrony events tended to be reduced with NAVA: 1.0events/min (0.5-3.1events/min) versus 4.4events/min (0.9-12.1events/min); p=0.08. AI was lower with NAVA: 4.9 % (2.5-10.5 %) versus 15.8 % (5.5-49.6 %); p=0.03. During NAVA, there were no ineffective efforts, or late or premature cyclings. PaO2 and PaCO2 were not different between ventilatory modes. Conclusion: Compared to PS, NAVA improved patient ventilator synchrony during noninvasive ventilation by reducing T d and AI. Moreover, with NAVA, ineffective efforts, and late and premature cyclings were absent

To the editor:H1N1 influenza infection is associated with severe forms of acuterespiratory distress syndrome (ARDS) with high mortality ratesamong younger subjects [1]. Evidence suggests improved outcomeswith the use of veno-venous extracorporeal membrane oxygenation(VV-ECMO) in the treatment of refractory hypoxemia associated withsevere cases of ARDS [2–5]. However, despite correct positioning ofthe cannulas and maximal ECMO blood flow, refractory hypoxemiamay persist. We describe how we improved arterial oxygenation of ayoungpatientwithsevereARDSbyreducingthepatient'snativecardiacoutput (CO) with beta-blockers.A 34-year old male, obese (BMI: 34), presented to the emergencydepartment with a history of fever, dyspnoea, cough and productivesputumworseningovertwoweeks.Atarrivalhewastachypneic,hemo-dynamicallystableandhemoglobinoxygensaturationwas89%inroomair. Chest radiography revealed right pulmonary infiltrates and bloodtestsweresignificantforleucopoenia,elevatedCRPandhighcreatinine.After 24 h of empiric treatment including oseltamivir, clarithromycineand ceftriaxone, the patient was admittedto intensive care with severeARDS. He was then sedated; intubated, paralyzed and low tidal volumeprotective lung ventilation with optimal PEEP was initiated. Corticoste-roids and inhaled nitric oxidewere alsostarted. Nasopharyngeal swabsrevealed influenza A infection.Despite recruitment maneuvers, PEEP 18–20 cm H

Transoesophageal Doppler monitoring allows non-invasive assessment of stroke volume. We studied haemodynamic changes during acute normovolemic haemodilution (ANH) in anaesthetised patients with coronary artery disease. Twenty patients were randomly assigned to either ANH or a control group. During ANH, a mean (SD) blood volume of 15.3 (3.4) ml.kg(-1) was withdrawn decreasing systemic oxygen delivery from 12.7 (3.3) to 9.3 (1.8) ml.kg(-1).min(-1) (p < 0.001). In the control group, haemodynamic data remained unchanged, whereas in the ANH group, stroke volume and central venous pressure increased significantly (mean = +21 ml [95% CI: 18-25 ml.min(-1)]; mean = +2.5 mmHg [95% CI: 2.2-2.8 mmHg], respectively) and heart rate decreased (mean = -6 beat.min(-1)[95% CI: 6-8 beat.min(-1)], p < 0.05). According to the Frank-Starling relationship, individual changes in stroke volume compared with central venous pressure fitted a quadratic regression model (R2 > 0.91). A reduced viscosity associated with ANH resulted in improved venous return, higher cardiac preload and increased cardiac output. In summary, this study demonstrated that ANH to a haemoglobin value of 8.6 g.dl(-1) was well tolerated in patients with coronary artery disease.